ENZYVANT
Live / Registered — Registered (as of 09 Jun 2020)
What this means for you
Registered since 09 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88330079
- Registration number
- 6072404
- Mark type
- Design + words
- Filed
- 07 Mar 2019
- Published for opposition
- 24 Mar 2020
- Registered
- 09 Jun 2020
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; pharmaceutical preparations for human use, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes for the treatment of rare or metabolic, acid ceramidase deficiency, pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto; biologic preparations for medical and therapeutic purposes, namely, tissue-based regenerative therapy to treat pediatric congenital athymia and thymus gland diseases, disorders and conditions, and immune deficiency related thereto
- Class 042 — Scientific and technological services: Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market clinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market clinical trials
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Owner
- Enzyvant Therapeutics GmbH, Basel, CH
- Enzyvant Therapeutics GmbH, Basel, CH
- Enzyvant Therapeutics GmbH, Basel, CH
Prosecution history
- 09 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 24 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2020 — PUBLISHED FOR OPPOSITION
- 04 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 10 Feb 2020 — ASSIGNED TO LIE
- 31 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jan 2020 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 31 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jan 2020 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 25 Jan 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 25 Jan 2020 — FINAL REFUSAL E-MAILED